Left unchecked, Europe’s narrow focus on AI investment will come at the health of half its population. As venture capital floods disproportionately into the AI sector, women’s health innovation — the definition of essential infrastructure — is once again left fighting for scraps. In 2021, global femtech investment peaked at €1.89bn before plunging to just €1.1bn the next year, amid a tech funding apocalypse and capital making a headlong dash towards AI. Several factors contributed to this decline — broader market conditions, withering investor risk appetite, and natural sector maturation. But the surge in AI funding coinciding with a plunge…
This story continues at The Next Web
